Triple-Leveraged Biotech ETFs Could be Coming Soon
March 20, 2015 at 14:40 PM EDT
Direxion, the second-largest issuer of leveraged exchange traded funds, has filed plans with the Securities and Exchange Commission to possibly introduce two triple-leveraged biotechnology ETFs. The Direxion Daily S&P Biotech Bull 3X Shares would attempt to deliver three times the daily...
